ORUM THERAPEUTICS

orum-therapeutics-logo

Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibody therapeutics. In contrast to other approaches, Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification.

#People #Financial #Event #Website #More

ORUM THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2016-01-01

Address:
Daejeon, Taejon-jikhalsi, South Korea

Country:
South Korea

Website Url:
http://www.orumrx.com

Total Employee:
11+

Status:
Active

Total Funding:
92 M USD

Technology used in webpage:
Viewport Meta Google Analytics Google Tag Manager Content Delivery Network Global Site Tag IPv6 Google Typekit Squarespace



Current Advisors List

not_available_image

Yeo Jung Moon Board of directors @ Orum Therapeutics
Board_member

peter-u-park_image

Peter U. Park Board Of Directors @ Orum Therapeutics
Board_member
2019-05-01

Current Employees Featured

not_available_image

Jaewon Kim
Jaewon Kim Chief Financial Officer @ Orum Therapeutics
Chief Financial Officer

olaf-christensen_image

Olaf Christensen
Olaf Christensen Chief Medical Officer @ Orum Therapeutics
Chief Medical Officer
2021-10-01

yong-sung-kim_image

Yong Sung KIM,
Yong Sung KIM, Scientific &Co- Founder @ Orum Therapeutics
Scientific &Co- Founder

peter-u-park_image

Peter U. Park
Peter U. Park Chief Scientific Officer @ Orum Therapeutics
Chief Scientific Officer
2019-01-01

sung-joo-lee_image

Sung Joo LEE
Sung Joo LEE CEO & Founder @ Orum Therapeutics
CEO & Founder
2016-08-01

Founder


sung-joo-lee_image

Sung Joo LEE

yong-sung-kim_image

Yong Sung KIM,

Investors List

imm-investment_image

IMM Investment

IMM Investment investment in Series B - Orum Therapeutics

atinum-investment_image

Atinum Investment

Atinum Investment investment in Series B - Orum Therapeutics

kbinvest_image

KB Investment

KB Investment investment in Series B - Orum Therapeutics

kdb-capital_image

KDB Capital

KDB Capital investment in Series B - Orum Therapeutics

kbinvest_image

KB Investment

KB Investment investment in Series B - Orum Therapeutics

intervest_image

InterVest

InterVest investment in Series B - Orum Therapeutics

smilegate-investment_image

Smilegate Investment

Smilegate Investment investment in Series B - Orum Therapeutics

ktb-network-2_image

KTB Network

KTB Network investment in Series B - Orum Therapeutics

solidus-investment_image

Solidus Investment

Solidus Investment investment in Series B - Orum Therapeutics

st-asset-management_image

ST Asset Management

ST Asset Management investment in Series B - Orum Therapeutics

Key Employee Changes

Date New article
2021-10-06 Orum Therapeutics Appoints Olaf Christensen, M.D., as Chief Medical Officer

Official Site Inspections

http://www.orumrx.com Semrush global rank: 4.9 M Semrush visits lastest month: 1.78 K

  • Host name: 198.49.23.144
  • IP address: 198.49.23.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Orum Therapeutics" on Search Engine